• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带杂合型KCNJ11突变的DEND综合征经磺脲类药物成功治疗

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.

作者信息

Cho Ja Hyang, Kang Eungu, Lee Beom Hee, Kim Gu Hwan, Choi Jin Ho, Yoo Han Wook

机构信息

Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Korea.

Medical Genetics Center, University of Ulsan College of Medicine, Asan Medical Center Children's Hospital, Seoul, Korea.

出版信息

J Korean Med Sci. 2017 Jun;32(6):1042-1045. doi: 10.3346/jkms.2017.32.6.1042.

DOI:10.3346/jkms.2017.32.6.1042
PMID:28480665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5426229/
Abstract

Permanent neonatal diabetes mellitus (PNDM) is caused by mutations in the ATP-sensitive potassium channel (KATP channel) subunits. Developmental delay, epilepsy, and neonatal diabetes (DEND) syndrome is the most severe form of PNDM and is characterized by various neurologic features. We report on a patient with DEND syndrome following initial misdiagnosis with type 1 DM, who was successfully switched from insulin to sulfonylurea therapy. A 50-day-old male presented with fever and seizure, complicated by persistent hyperglycemia. Insulin therapy was initiated. At 10 months of age, the patient was unable to hold his head up and make eye contact with others. At 17.9 years of age, direct sequencing of KCNJ11 identified a heterozygous mutation of c.602G>A (p.R201H). Since then, treatment with gliclazide was initiated and the insulin dose was gradually reduced. Following 3 months, insulin was discontinued with a gliclazide dose of 2.4 mg/kg. The patient continued to have excellent glycemic control with a glycated hemoglobin (HbA1c) level of 5.8% after 5 months. However, the patient's psychomotor retardation did not improve. This study reports the first case of DEND syndrome in Korea caused by a KCNJ11 mutation and emphasizes the necessity to screen mutations in KATP channel genes in patients with neonatal diabetes.

摘要

永久性新生儿糖尿病(PNDM)由ATP敏感性钾通道(KATP通道)亚基的突变引起。发育迟缓、癫痫和新生儿糖尿病(DEND)综合征是PNDM最严重的形式,其特征为各种神经学特征。我们报告了一例最初被误诊为1型糖尿病的DEND综合征患者,该患者成功地从胰岛素治疗转换为磺脲类药物治疗。一名50日龄男性出现发热和癫痫发作,并伴有持续性高血糖。开始胰岛素治疗。在10月龄时,该患者无法抬头且不能与他人进行眼神交流。在17.9岁时,对KCNJ11进行直接测序,发现了一个c.602G>A(p.R201H)的杂合突变。从那时起,开始使用格列齐特治疗,并逐渐减少胰岛素剂量。3个月后,停用胰岛素,格列齐特剂量为2.4mg/kg。5个月后,患者糖化血红蛋白(HbA1c)水平为5.8%,血糖控制仍极佳。然而,患者的精神运动发育迟缓并未改善。本研究报告了韩国首例由KCNJ11突变引起的DEND综合征病例,并强调对新生儿糖尿病患者筛查KATP通道基因突变的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/ac31e4520ff1/jkms-32-1042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/e46660fca1fb/jkms-32-1042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/3957e9220b73/jkms-32-1042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/ac31e4520ff1/jkms-32-1042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/e46660fca1fb/jkms-32-1042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/3957e9220b73/jkms-32-1042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5572/5426229/ac31e4520ff1/jkms-32-1042-g003.jpg

相似文献

1
DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.携带杂合型KCNJ11突变的DEND综合征经磺脲类药物成功治疗
J Korean Med Sci. 2017 Jun;32(6):1042-1045. doi: 10.3346/jkms.2017.32.6.1042.
2
Molecular and clinical features of K -channel neonatal diabetes mellitus in Japan.日本 K 通道新生儿糖尿病的分子和临床特征。
Pediatr Diabetes. 2017 Nov;18(7):532-539. doi: 10.1111/pedi.12447. Epub 2016 Sep 29.
3
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.KCNJ11 基因突变致新生儿糖尿病患者磺脲类药物长期治疗的有效性和安全性:一项国际队列研究。
Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4.
4
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.一种导致DEND综合征的新型突变:一种可治疗的胰腺和脑部通道病。
Neurology. 2007 Sep 25;69(13):1342-9. doi: 10.1212/01.wnl.0000268488.51776.53. Epub 2007 Jul 25.
5
Permanent neonatal diabetes mellitus due to KCNJ11 mutation in a Portuguese family: transition from insulin to oral sulfonylureas.葡萄牙一个家庭中因KCNJ11突变导致的永久性新生儿糖尿病:从胰岛素治疗过渡到口服磺脲类药物治疗
J Pediatr Endocrinol Metab. 2012;25(3-4):367-70. doi: 10.1515/jpem-2011-0191.
6
Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.越南国家儿童医院的 K-通道新生儿糖尿病的分子遗传学、临床特征和治疗结果。
Front Endocrinol (Lausanne). 2021 Sep 9;12:727083. doi: 10.3389/fendo.2021.727083. eCollection 2021.
7
Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation.新生儿糖尿病:两例因纯合型PTF1A增强子突变导致孤立性胰腺发育不全,一例因KCNJ11突变导致发育迟缓、癫痫和新生儿糖尿病综合征
J Clin Res Pediatr Endocrinol. 2018 Jun 1;10(2):168-174. doi: 10.4274/jcrpe.5162. Epub 2017 Sep 25.
8
Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene.由KCNJ11基因新突变引起的永久性新生儿糖尿病。
J Pediatr Endocrinol Metab. 2014 Mar;27(3-4):367-71. doi: 10.1515/jpem-2013-0068.
9
Novel perspectives of super-high dose sulfonylurea and high-dose oral prednisolone in an infant with DEND syndrome due to V64M heterozygote KCNJ11 mutation.DEND 综合征患儿伴 KCNJ11 错义突变 V64M 杂合子,采用新型超大剂量磺脲类药物和高剂量口服泼尼松治疗的研究进展
Acta Diabetol. 2021 Dec;58(12):1665-1672. doi: 10.1007/s00592-021-01763-1. Epub 2021 Jul 16.
10
Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.病例报告:亡羊补牢,为时未晚,但早做更好:两名 KCNJ11 变异致新生儿糖尿病患者由 CSII 转用磺脲类药物。
Front Endocrinol (Lausanne). 2023 May 11;14:1143736. doi: 10.3389/fendo.2023.1143736. eCollection 2023.

引用本文的文献

1
Neonatal and Syndromic Forms of Diabetes.新生儿糖尿病及综合征型糖尿病
Curr Diab Rep. 2025 Mar 25;25(1):26. doi: 10.1007/s11892-024-01567-x.
2
Precision therapy for Developmental delay, Epilepsy and Neonatal Diabetes syndrome in the era of genomics.基因组学时代发育迟缓、癫痫和新生儿糖尿病综合征的精准治疗
Med J Armed Forces India. 2024 Dec;80(Suppl 1):S337-S340. doi: 10.1016/j.mjafi.2024.01.007. Epub 2024 Feb 26.
3
Case report: Neonatal diabetes mellitus caused by mutation presenting with intracranial hemorrhage.病例报告:由突变引起的新生儿糖尿病伴颅内出血。

本文引用的文献

1
Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation.一名患有新型KCNJ11突变的永久性新生儿糖尿病患者磺脲类药物治疗成功。
Korean J Pediatr. 2015 Aug;58(8):309-12. doi: 10.3345/kjp.2015.58.8.309. Epub 2015 Aug 21.
2
Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.6 个月龄前确诊 1 型糖尿病病例的再评估。
Nat Rev Endocrinol. 2010 Jun;6(6):347-51. doi: 10.1038/nrendo.2010.42. Epub 2010 Apr 6.
3
The K(ATP) channel and neonatal diabetes.
Front Neurol. 2023 Mar 3;14:1072078. doi: 10.3389/fneur.2023.1072078. eCollection 2023.
4
Light-stimulated insulin secretion from pancreatic islet-like organoids derived from human pluripotent stem cells.光刺激人多能干细胞来源的胰岛类器官的胰岛素分泌。
Mol Ther. 2023 May 3;31(5):1480-1495. doi: 10.1016/j.ymthe.2023.03.013. Epub 2023 Mar 16.
5
Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region.西太平洋地区内或来自该地区的非欧洲裔人群中儿童和青少年糖尿病的流行病学及表型
World J Clin Pediatr. 2022 Mar 9;11(2):173-195. doi: 10.5409/wjcp.v11.i2.173.
6
Cognitive deficits and impaired hippocampal long-term potentiation in K-induced DEND syndrome.K 诱导的 DEND 综合征中的认知缺陷和海马长时程增强受损。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2109721118.
7
Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital.越南国家儿童医院的 K-通道新生儿糖尿病的分子遗传学、临床特征和治疗结果。
Front Endocrinol (Lausanne). 2021 Sep 9;12:727083. doi: 10.3389/fendo.2021.727083. eCollection 2021.
8
Etiologic distribution and clinical characteristics of pediatric diabetes in 276 children and adolescents with diabetes at a single academic center.276 例儿童和青少年糖尿病患者的病因分布和临床特征。
BMC Pediatr. 2021 Mar 4;21(1):108. doi: 10.1186/s12887-021-02575-6.
9
Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11.一名因KCNJ11基因p.G53D突变而患糖尿病的3个月大婴儿成功从胰岛素转换为磺脲类药物治疗。
Ann Pediatr Endocrinol Metab. 2018 Sep;23(3):154-157. doi: 10.6065/apem.2018.23.3.154. Epub 2018 Sep 28.
钾离子通道与新生儿糖尿病
Endocr J. 2009;56(2):165-75. doi: 10.1507/endocrj.k08e-160. Epub 2008 Jun 20.
4
Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.两名韩国患者因编码Kir6.2的KCNJ11基因杂合突变导致胰岛素治疗的新生儿糖尿病,接受磺脲类药物治疗。
J Korean Med Sci. 2007 Aug;22(4):616-20. doi: 10.3346/jkms.2007.22.4.616.
5
A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.一种导致DEND综合征的新型突变:一种可治疗的胰腺和脑部通道病。
Neurology. 2007 Sep 25;69(13):1342-9. doi: 10.1212/01.wnl.0000268488.51776.53. Epub 2007 Jul 25.
6
ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.ATP敏感性钾通道——新生儿糖尿病及其他情况
N Engl J Med. 2006 Aug 3;355(5):507-10. doi: 10.1056/NEJMe068142.
7
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.因Kir6.2突变导致糖尿病的患者从胰岛素转换为口服磺脲类药物治疗。
N Engl J Med. 2006 Aug 3;355(5):467-77. doi: 10.1056/NEJMoa061759.
8
Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.编码Kir6.2的KCNJ11基因突变是出生后6个月内诊断出的糖尿病的常见病因,其表型由基因型决定。
Diabetologia. 2006 Jun;49(6):1190-7. doi: 10.1007/s00125-006-0246-z. Epub 2006 Apr 12.
9
Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.Kir6.2基因激活突变与新生儿糖尿病:新的临床综合征、新的科学见解及新疗法
Diabetes. 2005 Sep;54(9):2503-13. doi: 10.2337/diabetes.54.9.2503.
10
Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients.在一大群法国患者中,Kir6.2突变是永久性新生儿糖尿病的常见病因。
Diabetes. 2004 Oct;53(10):2719-22. doi: 10.2337/diabetes.53.10.2719.